Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis
- PMID: 15723230
- DOI: 10.1007/s00213-005-2183-9
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis
Abstract
Rationale: The effect of LSD in humans has been described as occurring in two temporal phases. The behavioral effects in rats also occur in two temporal phases: an initial suppression of exploration followed by increased locomotor activity.
Objectives: We decided to investigate this phenomenon from the perspective that the pharmacology might have relevance to the neurochemical mechanisms underlying psychosis.
Methods: Twenty-five male Sprague-Dawley rats were trained to discriminate LSD (186 nmol/kg, 0.08 mg/kg, i.p.) with a 30-min preinjection time (LSD-30, N=12) and LSD (372 nmol/kg, 0.16 mg/kg, i.p.) with a 90-min preinjection time (LSD-90, N=13) from saline, using a two-lever, food-reinforced operant conditioning task.
Results: LSD (186 or 372 nmol/kg, 0.08 or 0.16 mg/kg) given 30 min prior to training produced a cue that was completely antagonized by 5-HT2A antagonists and lasted no longer than 1 h. LSD (372 nmol/kg, 0.16 mg/kg) injected 90 min before training produced a cue that was not fully blocked by 5-HT2A antagonists, but instead was significantly inhibited by haloperidol. In these rats, substitution no longer occurred with the 5-HT2 agonists DOI or LSD (30 min preinjection), but full substitution was obtained with the D2 agonists apomorphine, N-propyldihydrexidine, and quinelorane.
Conclusion: The discriminative stimulus effect of LSD in rats occurs in two phases, and these studies provide evidence that the later temporal phase is mediated by D2 dopamine receptor stimulation. A second temporal phase that involves dopaminergic pathways would be consistent with the widespread belief that excessive dopaminergic activity may be an underlying cause of paranoid psychosis.
Similar articles
-
Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.Pharmacol Biochem Behav. 2007 Oct;87(4):453-61. doi: 10.1016/j.pbb.2007.06.001. Epub 2007 Jun 14. Pharmacol Biochem Behav. 2007. PMID: 17618679
-
Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.Neuropsychopharmacology. 2005 Sep;30(9):1693-702. doi: 10.1038/sj.npp.1300711. Neuropsychopharmacology. 2005. PMID: 15756304
-
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.Psychopharmacology (Berl). 2010 Feb;208(2):179-89. doi: 10.1007/s00213-009-1718-x. Epub 2009 Nov 25. Psychopharmacology (Berl). 2010. PMID: 19937319 Free PMC article.
-
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Int J Mol Sci. 2016 Nov 23;17(11):1953. doi: 10.3390/ijms17111953. Int J Mol Sci. 2016. PMID: 27886063 Free PMC article. Review.
-
Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent.Behav Brain Res. 1996;73(1-2):117-9. doi: 10.1016/0166-4328(96)00080-0. Behav Brain Res. 1996. PMID: 8788487 Review.
Cited by
-
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.Biology (Basel). 2023 Oct 28;12(11):1380. doi: 10.3390/biology12111380. Biology (Basel). 2023. PMID: 37997979 Free PMC article. Review.
-
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.Molecules. 2022 Apr 14;27(8):2520. doi: 10.3390/molecules27082520. Molecules. 2022. PMID: 35458717 Free PMC article. Review.
-
Dopamine and sense of agency: Determinants in personality and substance use.PLoS One. 2019 Mar 19;14(3):e0214069. doi: 10.1371/journal.pone.0214069. eCollection 2019. PLoS One. 2019. PMID: 30889224 Free PMC article.
-
Modeling anxiety using adult zebrafish: a conceptual review.Neuropharmacology. 2012 Jan;62(1):135-43. doi: 10.1016/j.neuropharm.2011.07.037. Epub 2011 Aug 9. Neuropharmacology. 2012. PMID: 21843537 Free PMC article. Review.
-
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.J Psychopharmacol. 2021 Apr;35(4):469-482. doi: 10.1177/0269881121991569. Epub 2021 Mar 1. J Psychopharmacol. 2021. PMID: 33645311 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
